Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Group 1 - Alector, Inc. is a clinical-stage biotechnology company focused on immuno-neurology, which addresses immune dysfunction as a cause of neurodegenerative diseases [2] - The company will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference on June 27, 2024, with a webcast available for investors [1] - Alector's product candidates aim to treat conditions such as Alzheimer's disease and genetically defined frontotemporal dementia, supported by biomarkers [2] Group 2 - Alector is headquartered in South San Francisco, California, and is pioneering a novel therapeutic approach for neurodegenerative diseases [2] - The company has developed a broad portfolio of innate immune system programs to repair genetic mutations affecting the brain's immune system [2]